BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20732716)

  • 1. The prevalence and pharmacotherapy of depression in cancer patients.
    Ng CG; Boks MP; Zainal NZ; de Wit NJ
    J Affect Disord; 2011 Jun; 131(1-3):1-7. PubMed ID: 20732716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression in cancer patients--with focus on cancer patients in the palliative stage].
    Pedersen L; Birket-Smith M
    Ugeskr Laeger; 2007 Oct; 169(44):3765-8. PubMed ID: 18028846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
    Ostacher MJ
    Psychiatr Clin North Am; 2007 Mar; 30(1):69-76. PubMed ID: 17362804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients.
    Pirl WF
    J Natl Cancer Inst Monogr; 2004; (32):32-9. PubMed ID: 15263039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder.
    Papakostas GI; Petersen TJ; Perlis RH; Judy AE; Burns AM; Alpert JE; Birnbaum RJ; Fava M
    J Clin Psychopharmacol; 2006 Apr; 26(2):216-8. PubMed ID: 16633159
    [No Abstract]   [Full Text] [Related]  

  • 6. Major depression after breast cancer: a review of epidemiology and treatment.
    Fann JR; Thomas-Rich AM; Katon WJ; Cowley D; Pepping M; McGregor BA; Gralow J
    Gen Hosp Psychiatry; 2008; 30(2):112-26. PubMed ID: 18291293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of major depression in Belgian parkinsonian patients.
    Vanderheyden JE; Gonce M; Bourgeois P; Cras P; De Nayer AR; Flamez A; Supiot F; Donneau AF; Albert A; Berlaimont V;
    Acta Neurol Belg; 2010 Jun; 110(2):148-56. PubMed ID: 20873444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Algorithm for the treatment of major depression in patients with advanced cancer.
    Nakano T; Kugaya A; Akechi T; Mikami I; Okuyama T; Okamura H; Uchitomi Y
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S61-5. PubMed ID: 10560901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?
    Correa R; Akiskal H; Gilmer W; Nierenberg AA; Trivedi M; Zisook S
    J Affect Disord; 2010 Dec; 127(1-3):10-8. PubMed ID: 20655113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Editor's Roundtable: major depression in patients with coronary heart disease.
    Friedewald VE; Arnold LW; Carney RM; Jaffe AS; Sheps DS; Roberts WC
    Am J Cardiol; 2007 Feb; 99(4):519-29. PubMed ID: 17293197
    [No Abstract]   [Full Text] [Related]  

  • 11. Major depressive disorder treatment guidelines in China.
    Zhang M
    J Clin Psychiatry; 2010; 71 Suppl E1():e06. PubMed ID: 20371033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'Weight' of recurrent depression: a comparison between individuals with recurrent depression and the general population and the influence of antidepressants.
    Lok A; Visscher TL; Koeter MW; Assies J; Bockting CL; Verschuren WM; Gill A; Schene AH
    Psychother Psychosom; 2010; 79(6):386-8. PubMed ID: 20829650
    [No Abstract]   [Full Text] [Related]  

  • 13. Milnacipran treatment of a terminally ill cancer patient with major depressive disorder.
    Sato K; Higuchi H; Yoshida K; Takahashi H; Shimizu T; Watanabe J
    Hum Psychopharmacol; 2004 Aug; 19(6):431-2. PubMed ID: 15303248
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent psychotherapy and pharmacotherapy in the treatment of depression and anxiety in cancer patients.
    Twillman RK; Manetto C
    Psychooncology; 1998; 7(4):285-90. PubMed ID: 9741067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and the cancer patient.
    Massie MJ; Holland JC
    J Clin Psychiatry; 1990 Jul; 51 Suppl():12-7; discussion 18-9. PubMed ID: 2195008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical overview of the pharmacologic management of treatment-resistant depression.
    Nierenberg AA; Katz J; Fava M
    Psychiatr Clin North Am; 2007 Mar; 30(1):13-29. PubMed ID: 17362800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
    Trivedi MH; Lin EH; Katon WJ
    CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misleading report on the prevention of major depression among patients with head and neck cancer.
    Coyne JC
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1345; author reply 1345-6. PubMed ID: 19075135
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major depression and demoralization in cancer patients: diagnostic and treatment considerations.
    Angelino AF; Treisman GJ
    Support Care Cancer; 2001 Jul; 9(5):344-9. PubMed ID: 11497387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.